EDGAR Filing Documents for 0000000000-17-026141

Form UPLOAD - SEC-generated letter:

SEC Accession No. 0000000000-17-026141

Filing Date

2017-07-25

Accepted

2017-07-25 17:17:26

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.pdf	LETTER	112107
	Complete submission text file	0000000000-17-026141.txt		155142

Mailing Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017

Business Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017 212-874-6608

AngioGenex, Inc. (Filed for) CIK: 0001085596 (see all company filings)

IRS No.: 860945116 | State of Incorp.: NV | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations